Carrier erythrocytes: An overview

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 10, Issue 1, 2003, Pages 9-20

  Hamidi, Mehrdad ^a   Tajerzadeh, Hosnieh ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier Erythrocytes; Cellular Carriers; Erythrocyte; Erythrocyte Based Drug Delivery

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; CARDIOVASCULAR AGENT; CYANOCOBALAMIN; CYTARABINE; DEXAMETHASONE; DEXTRAN; DRUG CARRIER; ENALAPRILAT; GENTAMICIN; GLUTARALDEHYDE; HEPARIN; HYDROCORTISONE SODIUM PHOSPHATE; ISONIAZID; LYSINE; METHOTREXATE; METRONIDAZOLE; PEPTIDE; PHENYLALANINE; PHENYTOIN; POLYNUCLEOTIDE; PREDNISOLONE HEMISUCCINATE; PRIMAQUINE; PROPRANOLOL; PROPRANOLOL DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; THIAMINE DERIVATIVE; UNINDEXED DRUG; UROGASTRONE;

BIOCOMPATIBILITY; BIODEGRADABILITY; CELL FUSION; CELL TRANSFER; CYTOLOGY; DELAYED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TRANSPORT; ENZYME THERAPY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FRAGILITY; ERYTHROCYTE KINETICS; ERYTHROCYTE SHAPE; HUMAN; HUMAN CELL; LIFESPAN; MEMBRANE BINDING; OXYGEN TISSUE LEVEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RETICULOENDOTHELIAL NEOPLASM; REVIEW;

EID: 0037275959     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/713840329     Document Type: Review

References (111)

1. Green, R., and Widder, K. J. 1987. Methods in Enzymology, vol. 149. San Diego: Academic Press.
2. Ropars, C., Chassaigne, M., and Nicoulau, C. 1987. Advances in the Bloscicences, vol. 67. Oxford: Pergamon Press.
3. Lewis, D. A., and Alpar, H. O. 1984. Therapeutic possibilities of drugs encapsulated in erythrocytes. Int. J. Pharm. 22:137-146.
4. Zimmermann, U. 1983. Cellular drug-carrier systems and their possible targeting. In Targeted Drugs, ed. E. P. Goldberg, 153-200. New York: John Wiley & Sons.
5. Jaitely, V., Kanaujia, P., Venkatesan, N., Jain, S., and Yyas, S. P. 1996. Resealed erythrocytes: Drug carrier potentials and biomedical applications. Indian Drugs 33:589-594.
6. Jain, S., and Jain, N. K. 1997. Engineered erythrocytes as a drug delivery system. Indian J. Pharm. Sci. 59:275-281.
7. Telen, M. J. 1993. The mature erythrocytes. In Winthrob's Clinical Hematology, 9th ed., eds. R. Lee, T. C. Bithel, J. Foerster, J. W. Athens, J. N. Lukens, 101-133. Philadelphia: Lea & Febiger.
8. Gardos, G. 1953. Akkumulation de kalium onen durch menschiche Blutkorperchen. Acta Physiol. Acad. Sci. Hung. 6:191-196.
9. Marsden, N. V. B., and Ostling, S. G. 1959. Accumulation of dextran in human red blood cells after hemolysis. Nature 184:723-724.
10. Iher, G. M., Glew, R. M., and Schnure, F. W. 1973. Enzyme loading of erythrocytes. Proc. Natl. Acad. Sci. USA 70:2663-2666.
11. Zimmermann, U. 1973. Jahresbericht der kemforschungsanlage Julich GmbH, Nuclear Research Center Julich, 55-58.
12. Guyton, A. C., and Hall, J. E. 1996. Red blood cells, anemia and polycytemia. In Textbook of Medical Physiology, 425-433. Philadelphia: W.B. Saunders.
13. Cooney, D. O. 1976. Biomedical Engineering Principles. New York: Marcel Dekker Inc.
14. Connor, J., and Schroit, A. J. 1987. Red blood cell recognition by the reticuloendothelial system. Adv. Biosci. (series) 67:163-171.
15. Schlegel, R. A., McEvoy, L., Weiser, M., and Williamson, P. 1987. Phospholipid organization as a determinant of red cell recognition by the reticuloendothelial system. Adv. Biosci. (series) 67:173-181.
16. Updike, S. J., and Wakamiya, R. T. 1983. Infusion of red blood cell-loaded asparaginase in monkey. J. Lab. Clin. Med. 101:679-691.
17. Alpar, H. O., and Irwin, W. J. 1987. Some unique applications of erythrocytes as carrier systems. Adv. Biosci. (series) 67:1-9.
18. Eichler, H. C., Gasic, S., Daum, B., Bacher, S., and Steger, G. 1987. In vitro drug release from human carrier erythrocytes. Adv. Biosci. (series) 67:11-15.
19. Summers, M. P. 1983. Recent advances in drug delivery. Pharm. J. 230:643-645.
20. Talwar, N., and Jain, N. K. 1992. Erythrocytes as carriers of primaquinpreparation: Characterization and evaluation. J. Control. Rel. 20: 133-142.
21. Lewis, D. A. 1984. Red blood cells for drug delivery. Pharm. J. 233:384-385.
22. Adriaenssens, K., Karcher, D., Lowenthal, A., and Terheggen, H. G. 1976. Use of enzyme-loaded erythrocytes in in-vitro correction of arginasedeficient erythrocytes in familiar hyperargininemia. Clin. Chem. 22:323-326.
23. Sprandel, U. 1987. Towards cellular drug targeting and controlled release of drugs by magnetic fields. Adv. Adv. Biosci. (series) 67:243-250.
24. Jenner, D. J., Lewis, D. A., Pitt, E., and Offord, R. A. 1981. The effect of the intravenous administration of corticosteroids encapsulated in intact erythrocytes on adjuvant arthritis in the rat. Br. J. Pharmacol. 73:212P-213P.
25. Kinosita, K., and Tsong, T. Y. 1978. Survival of sucrose-loaded erythrocytes in the circulation. Nature 272:258-260.
26. Alpar, H. O., and Lewis, D. A. 1985. Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. Biochem. Pharmacol. 34:257-261.
27. Eichler, H. G., Gasic, S., Bauer, K., Korn, A., and Bacher, S. 1986. In vivo clearance of antibody-sensitized human drug carrier erythrocytes. Clin. Pharmacol. Ther. 40:300-303.
28. Baker, R. 1967. Entry of ferritin into human red cells during hypotonic haemolysis. Nature 215:424-425.
29. Ihler, G. M., and Tsang, H. C. W. 1987. Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes. Methods Enzymol. (series) 149:221-229.
30. Vienken, J., Jeltsch, E., and Zimmermann, U. 1978. Penetration and entrapment of large particles in erythrocytes by electrical breakdown techniques. Cytobiologie 17:182-186.
31. Jain, S., Jain, S. K., and Dixit, V. K. 1995. Erythrocytes based delivery of isoniazid: Preparation an in vitro characterization. Indian Drugs 32:471-476.
32. Pitt, E., Lewis, D. A., and Offord, R. 1983. The use of corticosteroids encapsulated in erythrocytes in the treatment of adjuvant induced arthritis in the rat. Biochem. Pharmacol. 132:3355-3358.
33. Tajerzadeh, H., and Hamidi, M. 2000. Evaluation of the hypotonic preswelling method for encapsulation of enalaprilat in human intact erythrocytes. Drug Devel. Ind. Pharm. 26:1247-1257.
34. Hamidi, M., Tajerzadeh, H., Rouini, M. R., Dehpour, A. R., and Ejtemaee-Mehr Sh. 2001. In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Delivery 8:231-237.
35. Benatti, U., Zocchl, E., Tonetti, M., Guida, L., and DeFlora, A. 1987. Comparative tissue distribution and metabolism of free versus erythrocyte-encapsulated adriamycin in the mouse. Adv. Biosci. (series) 67: 129-136.
36. Deloach, J. R., Harris, R. L., and Ihler, G. M. 1980. An erythrocyte encapsulator dialyzer used in preparing large quantities of erythrocyte ghosts and encapsulation of a pesticide in erythrocyte ghosts. Anal Biochem. 102:220-227.
37. Ihler, G. M. 1983. Erythrocyte carriers. Pharmacol. Ther. 20:151-169.
38. Pitt, E., Johnson, C. M., Lewis, D. A., Jenner, D. A., and Offord, R. 1983. Encapsulation of drugs in intact erythrocytes: An intravenous delivery system. Biochem. Pharmacol. 22:3359-3368.
39. Deloach, J. R., and Ihler, G. M. 1977. A dialysis procedure for loading of erythrocytes with enzymes and lipids. Biochim. Biophys. Acta 496:136-145.
40. Talwar, N., and Jain, N. K. 1992. Erythrocytes as carriers of metronidazole: In-vitro characterization. Drug Devel. Ind. Pharm. 18:1799-1812.
41. Updike, S. J., Wakarniya, R. T., and Lightfoot, E. N. 1976. Asparaginase entrapped in red blood cells: Action and survival. Science 193:681-683.
42. Bhaskaran, S., and Dhir, S. S. 1995. Resealed erythrocytes as carriers of Salbutamol sulphate. Indian J. Pharm. Sci. 57:240-242.
43. Klibansky, C. 1959. Ph.D. Thesis, Hebrew University, Jerusalem, Israel.
44. Dale, G. L., Villacorte, D. G., and Beutler, E. 1977. High yield entrapment of protein into erythrocytes. Blochem. Med. 18:220-225.
45. Kravtozoff, R., Ropars, C., Laguerre, M., Muh, J. P., and Chassaigne, M. 1990. Erythrocytes as carriers for L-asparaginase: Methodological and mouse in-vivo studies. J. Pharm. Pharmacol. 42:473-476.
46. Jrade, M., Villereal, M. C., Boynard, M., Dufaux, J., and Ropars, C. 1987. Rheological approach to human red blood cell carriers desferrioxamine encapsulation. Adv. Biosci. (series) 67:29-36.
47. Berman, J.D. 1987. Antileishmanial activity of red cell encapsulated drugs. Adv. Biosci. (series) 67:145-152.
48. Deloach, J. R., Andrews, K., Sheffield, C. L., and Koths, K. 1987. Subcutaneous administration of [35-S] r-IL-2 in mice carrier erythrocytes: Alteration of IL-2 pharmacokinetics. Adv. Biosci. (series) 67:183-190.
49. Deloach, J. R., and Doleskey, R. 1987. Preparation and properties of microcytic carrier erythrocytes from sheep and goats. Adv. Biosci. (series) 67:199-212.
50. Ropars, C., Nicolau, C., and Chassaigne, M. 1982. French Patent No. 82. 11749; 1983. European Patent No. 83.401364-1.
51. Zanella, A., Rossi, F., Sabionedda, L., Russo, V., Brovelli, A., DeCal, F., Fargion, S., Fiorelli, G., and Sirchia, G. 1987. Desferrioxamine loading of red cells for transfusion. Adv. Biosci. (series) 67:17-27.
52. Fiorelli, G., Fargion, S., Piperno, A., Cappellini, M. D., Rossi, F., Sabbioneda, L., and Zanella, A. 1987. Transfusion of thalasemic patients with desferrioxamine loaded standard red blood cell units. Adv. Biosci. (series) 67:47-54.
53. Villereal, M. C., Bailleul, C., Chassaigne, M., and Ropars, C. 1987. Approach to optimization of inositol hexaphosphate entrapment into human red blood cells. Adv. Biosci. (series) 67:55-62.
54. Hurel, C., Ropars, C., Avenard, G. and Chassaigne, M. 1987. Optimization of desferrioxamine loading in red blood cells. Adv. Biosci. (series) 67: 37-46.
55. Villereal, M.C., Bailleul, C., Ropars, C., Nicolau, C., Casset, D., and Itti, R. 1987. Modification of cardiac parameters in piglets after infusion of IHP-loaded red blood cells. Adv. Biosci. (series) 67:81-88.
56. Teisseire, B., Ropars, C., Villereal, M. C., and Nicolau, C. 1987. In vivo consequences of rightward shift of the hemoglobin dissociation curve. Adv. Biosci. (series) 67:89-94.
57. Jrade, M., Ropars, C., Van Vooren, C., and Chassaigne, M. 1987. Technical aspects of human red blood cell carriers methodology. Adv. Biosci. (series) 67:223-232.
58. Garin, M. I., Lopez, R. M., Sanz, S., Pinilla, M., and Luque, J. 1996. Erythrocytes as carriers for recombinant human erythropoietin. Pharm. Res. 13:869-874.
59. Rechsteiner, M. C. 1975. Uptake of protein by red cells. Exp. Cell Res. 43:487-492.
60. Jain, S., Jain, S. K., and Dixit, V. K. 1997. Magnetically, guided rat erythrocytes bearing isoniazid: Preparation, characterization, and evaluation. Drug Devel. Ind. Pharm. 23:999-1006.
61. Field, W. N., Gamble, M. D., and Lewis, D. A. 1989. A comparison of treatment of thyroidectomized rats with free thyroxine and thyroxine encapsulated in erythrocytes. Int. J. Pharm. 51:175-178.
62. Kruse, C. A., James, G. T., Freehauf, C. L., and Williams, C. M. 1987. Methotrexate loaded erythrocytes carriers: Optimization their formation, their characterization, and their pharmacological efficiency in treating hepatoma 129 ascites tumors in mice. Adv. Biosci. (series) 67:137-144.
63. Bird, J., Best, R., and Lewis, D. A. 1983. The encapsulation of insulin in erythrocytes. J. Pharm. Pharmacol. 35:246-247.
64. Franco, R., Barker, R., and Weiner, M. 1987. The nature and kinetics of red cell membrane changes during the osmotic pulse method of incorporating xenobiotics into viable red cells. Adv. Biosci. (series) 67:63-72.
65. Deuticke, B., Kim, M., and Zolinev, C. 1973. The influence of amphotericin-B on the permeability of mammalian erythrocytes to nonelectrolytes, anions and cations. Biochim. Blophys. Acta 318:345-359.
66. Zimmermann, U., Riemann, F., and Pilwat, G. 1976. Enzyme loading of electrically homogenous human red blood cell ghosts prepared by dielectric breakdown. Biochim. Blophys. Acta 436:460-474.
67. Kinosita, K., and Tsong, T. Y. 1977. Hemolysis of human erythrocytes by a transient electric field. Proc. Natl. Acad. Sci. USA 74:1923-1927.
68. Kinosita, K., and Tsong, T. Y. 1977. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 268:438-441.
69. Dehpour, A. R., Jafar-Nejad, P., Mani, A., Garib, B., and Ebrahimi-Daryani, N. 1999. Chlorpromazine-induced erythrocyte shape change in rats with obstructive cholestasis. Pharm. Pharmacol. Comm. 5:615-618.
70. 12 from carrier erythrocytes in vitro. Res. Exp. Med. 185:341-344.
71. Lewis, D. A., and Desai, J. 1987. The use of animal models in the encapsulation of drugs in erythrocytes. Adv. Biosci. (series) 67:213-222.
72. Deloach, J. R. 1982. Comparative encapsulation of cytosine arabinoside monophosphate in human and canine erythrocyteswith in vitro drug efflux. J. Appl. Biochem. 4:533-541.
73. Stella, V. 1980. Prodrugs. In Drug Delivery Systems, ed. R. L. Juliano, 164-165. Oxford: Oxford University Press.
74. Way, J., Leung, P., Way, J. L., Sylvester, D., Tamulinas, C., Davis, R., Yao, C., and Que, B. 1987. Encapsulation of rhodanese by mouse carrier erythrocytes. Adv. Biosci. (series) 67:123-128.
75. Hamidi, M., Tajerzadeh, H., Dehpour, A.R., and Ejtemaee-Mehr, Sh. 2001. ACE inhibition in rabbits upon administration of enalaprilat-loaded intact erythrocytes. J. Pharm. Pharmacol. 53:1281-1289.
76. Green, R., Lamon, J., and Curran, D. 1980. Clinical trial of desferrioxamine entrapped in red cell ghosts. Lancet I:327-330.
77. Harris, R. C. 1977. Enzyme replacement in red cells. N. Eng. J. Med. 296:942-943.
78. Beutler, E., Dale, G. L., Guinto, E., and Kuhl, W. 1977. Enzyme replacement therapy in Gaucher's disease. Preliminary clinical trial of a new enzyme preparation. Proc. Natl. Acad. Sci. USA 74:4620-4623.
79. Deloach, J. R., and Barton, C. 1982. Circulating carrier erythrocytes: Slow release vehicle for an antileukemic drug, cytosine arabinoside. Am. J. Vet. Res. 43:2210-2212.
80. Al-Achi, A., and Boroujerdi, M. 1990. Pharmacokinetics and tissue uptake of doxorubicin associated with erythrocyte-membrane: Erythrocyte-ghosts vs. erythrocyte-vesicles. Drug Devel. Ind. Pharm. 16:2199-2219.
81. Kitao, T., Hattori, K., and Takeshita, M. 1978. Agglutination of leukemic cells and daunomycin entrapped erythrocytes with lectin in vitro and in vivo. Experimentia 341:94-95.
82. McLaren, G. D., Muir, W. A., and Kellermeyer, R. W. 1983. Iron overload disorders. Crit. Rev. Clin. Lab. Sci. 19:205-266.
83. Goldberg, D. M. 1992. Enzymes as agents for treatment of disease. Clinica Chimica Acta 206:45-76.
84. Alcira, M., and Bettle, D. C. 1987. On the successful use of enzyme loaded erythrocyte ghosts in the treatment o lead intoxication in animal and clinical experience. Adv. Biosci. (series) 67:103-112.
85. Magnani, M., Laguerre, M., Rossi, L., Bianchi, M., Ninfali, F., Mangani, F., and Ropars, C. 1989. Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for removal of blood acetaldehyde, alcoholism. Clin. Exp. Res. 13:849-859.
86. Ihler, G. W., Lantzy, A., Purpura, J., and Glew, R. H. 1975. Enzymatic degradation of uricase-loaded human erythrocytes. J. Clin. Invest. 56:595-602.
87. Morales, L. E. 1996. Gaucher's disease. Annal. Pharmacother. 30:381-388.
88. Tan, C. 1972. L-asparaginase in leukemia. Hosp. Pract. 7:99-103.
89. Terheggen, H. G., Lowenthal, A., Lavinha, F., and Colombo, J. 1975. Familial hyperargininemia. Arch. Dis. Child. 50:57-61.
90. Westley, J. 1973. Rhodanese. Adv. Enzymol. Rel. Areas Mol. Biol. 39:327-368.
91. Ibels, L. S., and Pollock, C. A. 1986. Lead intoxication. Med. Toxicol. 1:387-410.
92. Zocchi, E., Tonetti, M., Polvani, C., Guida, L., Benatti, V., and DeFlora, A. 1988. In-vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes. Biotechnol. Appl. Biochem. 10:555-562.
93. Deloach, J. R., Andrews, K., and Naqi, A. 1987. Erythrocytes as carriers of mycotoxins for targeting to the reticuloendothelial system. Adv. Biosci. (series) 67:191-198.
94. Deloach, J. R., Peters, S., Pinkard, O., Glew, R., and Ihler, G. M. 1977. Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes. Biochim. Biophys. Acta 496:507-515.
95. Dale, G. L., Kuhl, W., and Beutler, E. 1979. Incorporation of glucoserebrosidase into Gaucher's disease monocytes. Proc. Natl. Acad. Sci. USA 76:473-480.
96. Sprandel, U., Lanz, D. J., and Horsten, W. V. 1987. Magnetically responsive erythrocyte ghosts. Methods Enzymol. (series) 149:301-312.
97. Deloach, J. R., and Droleskey, R. 1986. Survival of murine carrier erythrocytes injected via peritoneum. Comp. Biochem. Physiol. 83A:447-450.
98. Guyton, A. C., and Hall, J. E. 1996. Transport of oxygen and carbon dioxide in the blood and body fluids. In Textbook of Medical Physiology, 513-523. Philadelphia: W.B. Saunders.
99. Arnone, A., and Perutz, M. F. 1974. Structure of inositol hexaphosphatehuman deoxyhaemoglobin complex. Nature 249:34-36.
100. 50 erythrocyte transfusion on piglets. J. Appl. Physiol. 58:1810-1817.
101. Baron, J. F., Vicaut, E., Stucker, O., Villareal, M. C., Ropars, C., Teisseire, B., and Duvelleroy, M. 1987. Isolated heart as a model to study the effects of the decrease in oxygen hemoglobin affinity. Adv. Biosci. (series) 67:73-78.
102. 50 shifts and tissue oxygen pressure. Adv. Biosci. (series) 67:79-80.
103. 2 affinity in isolated rat heart. Am. J. Physiol. 249:H1224-H1227.
104. Woodson, R. D., and Auerbach, S. 1982. Effect of increased oxygen affinity and anemia on cardiac output and its distribution. J. Appl. Physiol. 53:1299-1306.
105. Schlegel, R. A., and Rechsteiner, M. C. 1978. Red cell-mediated microinjection of macromolecules into mammalian cells. Methods Cell Biol. 20:341-354.
106. Loyter, A., Zakai, N., and Kulka, R. G. 1975. Ultramicroinjection of macromolecules or small particles into animal cells. J. Cell Biol. 66:292-305.
107. Wille, W., and Willecke, K. 1976. Retention of purified proteins in resealed human crythrocyte ghosts and transfer by fusion into cultured murine cells. FEBS Lett. 65:59-62.
108. Furusawa, M., Nishimura, T., Yamaizumi, M., and Okada, Y. 1974. Injection of foreign substances into single cells by cell fusion. Nature 249:449-450.
109. Schlegel, R. A., and McEvoy, L. 1987. Red cell-mediated microinjection. Methods Enzymol. (series) 149:293-301.
110. Kruse, C. A., Spector, E. B., Cederbaum, S. D., Wisnieski, B. J., and Popjak, G. 1981. Microinjection of arginase into enzyme-deficient cells with the isolated glycoprotein of sendai virus as fusogen. Biochim. Biophys. Acta 645:339-345.
111. Kruse, A., James, G. T., Cederbaum, S. D., and Spector, E. B. 1987. Arginase-loaded erythrocyte carriers: Their fusion to host cells with viral fusogenic proteins and subcellular localization of arginase. Adv. Biosci. (series) 67:113-122.